Self-rated residual symptoms do not predict 1-year recurrence of depression

European Psychiatry

Volumn 25, Issue 1, 2010, Pages 52-57

  Bertschy, G ^a   Haffen, E ^b   Gervasoni, N ^c   Gex Fabry, M ^a   Osiek, C ^a   Marra, D ^d   Aubry, J M ^a   Bondolfi, G ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Depression; Rating scale; Recurrence; Remission; Risk factors

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NATURALISTIC INQUIRY; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; RISK FACTOR; SAMPLE SIZE; SCORING SYSTEM; SELF CONCEPT; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECURRENCE; TIME FACTORS; YOUNG ADULT;

EID: 73649106573     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.05.009     Document Type: Article

References (44)

1. Alloy L.B., Abramson L.Y., Whitehouse W.G., Hogan M.E., Panzarella C., and Rose D.T. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. J Abnorm Psychol 115 (2006) 145-156
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed., text revision ed. Washington, DC: American Psychiatric Association; 2000.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
4. Beck A.T., Steer R.A., and Brown G.K. Beck Depression Inventory. 2nd ed. (1996), The Psychological Corporation, San Antonio, TX
5. Beevers C.G., Keitner G.I., Ryan C.E., and Miller I.W. Cognitive predictors of symptom return following depression treatment. J Abnorm Psychol 112 (2003) 488-496
6. Bockting C.L., Spinhoven P., Koeter M.W., Wouters L.F., and Schene A.H. Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study. J Clin Psychiatry 67 (2006) 747-755
7. Bondolfi G., Aubry J.M., Golaz J., Gex-Fabry M., Gervasoni N., and Bertschy G. A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study. Swiss Med Wkly 136 (2006) 78-85
8. Booij L., and Van der Does A.J. Cognitive and serotonergic vulnerability to depression: convergent findings. J Abnorm Psychol 116 (2007) 86-94
9. Boulenger J.P. Residual symptoms of depression: clinical and theoretical implications. Eur Psychiatry 19 (2004) 209-213
10. Cuffel B.J., Azocar F., Tomlin M., Greenfield S.F., Busch A.B., and Croghan T.W. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 64 (2003) 397-402
11. Dotoli D., Spagnolo C., Bongiorno F., Zanardi R., Serretti A., Smeraldi E., et al. Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 442-448
12. Fabbri S., Fava G.A., Rafanelli C., and Tomba E. Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. J Clin Psychiatry 68 (2007) 1348-1351
13. Faravelli C., Ambonetti A., Pallanti S., and Pazzagli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 143 (1986) 888-891
14. Fava G.A., Grandi S., Zielezny M., Canestrari R., and Morphy M.A. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151 (1994) 1295-1299
15. Fava G.A., Rafanelli C., Cazzaro M., Conti S., and Grandi S. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med 28 (1998) 475-480
16. Fava G.A., Ruini C., and Belaise C. The concept of recovery in major depression. Psychol Med 37 (2007) 307-317
17. Flint A.J., and Rifat S.L. Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants. Am J Psychiatry 156 (1999) 943-945
18. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48 (1991) 851-855
19. Fresco D.M., Segal Z.V., Buis T., and Kennedy S. Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. J Consult Clin Psychol 75 (2007) 447-455
20. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361 (2003) 653-661
21. Grunhaus L., Shipley J.E., Eiser A., Pande A.C., Tandon R., Remen A., et al. Shortened REM latency PostECT is associated with rapid recurrence of depressive symptomatology. Biol Psychiatry 36 (1994) 214-222
22. Hart A.B., Craighead W.E., and Craighead L.W. Predicting recurrence of major depressive disorder in young adults: a prospective study. J Abnorm Psychol 110 (2001) 633-643
23. Hawley C.J., Gale T.M., and Sivakumaran T. Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 72 (2002) 177-184
24. Healy D. The assessment of outcome in depression: measures of social functioning. Rev Contemp Pharmacother 11 (2000) 295-301
25. Israel J.A. Remission in depression: definition and initial treatment approaches. J Psychopharmacol 20 (2006) 5-10
26. Keller M.B., Kocsis J.H., Thase M.E., Gelenberg A.J., Rush A.J., Koran L., et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 280 (1998) 1665-1672
27. Melartin T.K., Rytsala H.J., Leskela U.S., Lestela-Mielonen P.S., Sokero T.P., and Isometsa E.T. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 65 (2004) 810-819
28. Mongrain M., and Leather F. Immature dependence and self-criticism predict the recurrence of major depression. J Clin Psychol 62 (2006) 705-713
29. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
30. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., and Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25 (1995) 1171-1180
31. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163 (2006) 1905-1917
32. Segal Z.V., Shaw B.F., Vella D.D., and Katz R. Cognitive and life stress predictors of relapse in remitted unipolar depressed patients: test of the congruency hypothesis. J Abnorm Psychol 101 (1992) 26-36
33. Segal Z.V., Williams J.M., Teasdale J.D., and Gemar M. A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol Med 26 (1996) 371-380
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (1998) 22-33 quiz 34-57
35. Simons A.D., Murphy G.E., Levine J.L., and Wetzel R.D. Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43 (1986) 43-48
36. Teasdale J.D., Scott J., Moore R.G., Hayhurst H., Pope M., and Paykel E.S. How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. J Consult Clin Psychol 69 (2001) 347-357
37. Viguera A.C., Baldessarini R.J., and Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 5 (1998) 293-306
38. Wang C.E., Brennen T., and Holte A. Mechanisms of recurrent depression: a cognitive battle model and some preliminary results. Clin Psychol Psychother 12 (2005) 427-442
39. Zimmerman M., Posternak M.A., and Chelminski I. Defining remission on the Montgomery-Asberg depression rating scale. J Clin Psychiatry 65 (2004) 163-168
40. Zimmerman M., Posternak M.A., and Chelminski I. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 38 (2004) 577-582
41. Zimmerman M., McGlinchey J.B., Posternak M.A., Friedman M., Boerescu D., and Attiullah N. Differences between minimally depressed patients who do and do not consider themselves to be in remission. J Clin Psychiatry 66 (2005) 1134-1138
42. Zimmerman M., Posternak M.A., and Chelminski I. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?. J Nerv Ment Dis 193 (2005) 170-175
43. Zimmerman M., McGlinchey J.B., Posternak M.A., Friedman M., Attiullah N., and Boerescu D. How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry 163 (2006) 148-150
44. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 35 (2001) 83-94